| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |